Physiological and pathological roles of cysteine proteases make them import
ant tar gets for inhibitor development. Although highly potent inhibitors o
f this group of enzymes are known, their major drawback is a lack of suffic
ient specificity. Two cysteine protease covalent inhibitors, viz. (i) Z-RL-
deoxo-V-peptide-epoxysuccinyl hybrid, and (ii) Z-RLVG-methyl-, have been de
veloped and modeled in the catalytic pocket of papain, an archetypal thiol
protease. A number of configurations have been generated and relaxed for ea
ch system using the AMBER force field. The catalytic pockets S-3 and S-4 ap
pear rather elusive in view of the observed inhibitors' flexibility. This s
uggest rather limited chances for the development of selective structure-ba
sed inhibitors of thiol proteases, designed to exploit differences in the s
tructure of catalytic pockets of various members of this family.